Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled ambroxol hydrochloride for sticky sputum in lower respiratory tract infections
ChiCTR2300072467Phase 3Completed
- Sponsor
- Peking University People's Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pulmonary infection, chronic bronchitis (CB), pneumonia and 1 more comparing Experimental arm: inhaled ambroxol hydrochloride solution with Control arm: placebo inhalation solution (2 arms). Primary endpoint: Sputum traits. Started Jun 2023; status: completed.
02
Drugs
ambroxol
03
Conditions
pulmonary infectionchronic bronchitis (CB)pneumoniachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2300072467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072467.